Clinical Trials Logo

Clinical Trial Summary

Phantom limb pain (PLP) is a significant and pervasive issue among upper limb amputees, severely impacting their quality of life. The literature delineating prevalence of upper versus lower limb amputations is limited, but the prevalence of total amputations in the United States is estimated to reach 3 million individuals by 2050, with approximately 185,000 new cases annually. PLP affects 60-68% of these patients, leading to heightened levels of anxiety, depression, and reduced overall well-being.


Clinical Trial Description

Although studies exploring the efficacy of VR therapy for PLP have reported positive outcomes, several limitations, such as small sample sizes, lack of randomization, and inconsistent treatment protocols, have impeded widespread adoption of these innovative approaches. Additionally, the literature does not sufficiently delineate which aspects of the phantom limb experience may be addressed with VR therapy. To overcome these limitations and optimize treatment efficacy, it is crucial to gain a comprehensive understanding of the phantom limb experience, including both somatosensory and kinesthesia-related symptoms. Additionally, this study will address these limitations by employing a larger sample size, rigorous methodology, and a standardized treatment protocol. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06077227
Study type Interventional
Source Wake Forest University Health Sciences
Contact Joshua Steinke
Phone 704-942-4351
Email joshua.steinke@orthocarolina.com
Status Recruiting
Phase N/A
Start date December 31, 2023
Completion date October 2024

See also
  Status Clinical Trial Phase
Withdrawn NCT02696720 - A Trial of Lidocaine Patch for Lower Limb Amputation Pain Phase 2